beta

AKBA

Akebia Therapeutics, Inc.

Akba

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Market Cap: 755 Million

Primary Exchange: NASDAQ

Website: http://www.akebia.com

Shares Outstanding: 119 Million

Float: 106 Million

Dividend: (%)

Beta: 1.93196120878567

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 1905 trading days

From: 2014-06-20 To: 2019-12-12

Lowest Point:

Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

via: Business Wire at 2019-06-11 03:30:00:000

AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...

Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

via: Business Wire at 2019-06-11 03:30:00:000

AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...

Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

via: Business Wire at 2019-06-11 03:30:00:000

AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud